Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,1.693523410724252e-46,158.61557177615572,16716.82868766061,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.589448443062723e-44,0,0,67
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.461401133758266e-24,36.45903890160183,2000.9685465255661,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UCP3', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'COX8A', 'ATP5PF', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",1.9801985362424505e-22,0,0,41
3,Nonalcoholic fatty liver disease WP4396,2.3809409403086844e-20,23.26433430515063,1051.1804759594377,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'COX8A', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",2.150783316078845e-18,0,0,37
4,Mitochondrial complex I assembly model OXPHOS system WP4324,1.5424265611493126e-13,inf,inf,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC1', 'TMEM186', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",1.0449939951786593e-11,0,0,18
5,Oxidative phosphorylation WP623,1.1734404489606748e-10,20.11764705882353,460.0083259983318,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",6.3600472333668576e-09,0,0,19
6,Mitochondrial CIV Assembly WP4922,1.579806722691968e-07,14.663793103448276,229.6466304234444,"['COX8A', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",7.135460364158722e-06,0,0,14
7,Mitochondrial complex III assembly WP4921,2.1662334987444863e-06,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",8.386418259425083e-05,0,0,8
8,Pyrimidine metabolism WP4022,0.006201050540857315,4.127659574468085,20.98104452099867,"['NT5C', 'POLD4', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K', 'NME1', 'POLR2L']",0.21006058707154154,0,0,8
9,Nanoparticle triggered regulated necrosis WP2513,0.025966260290106513,12.296842105263158,44.89524501864991,"['TRADD', 'FADD', 'FTL']",0.7818729487354295,0,0,3
10,Nanomaterial induced apoptosis WP2507,0.03146236999440468,5.471167369901547,18.92456577619331,"['ENDOG', 'BAX', 'CYCS', 'FADD']",0.807918377009828,0,0,4
11,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.038756232107482524,inf,inf,"['COX8A', 'GSTP1']",0.807918377009828,0,0,2
12,CAMKK2  Pathway WP4874,0.038756232107482524,inf,inf,"['FIS1', 'MAP1LC3A']",0.807918377009828,0,0,2
13,Cellular Proteostasis WP4918,0.038756232107482524,inf,inf,"['VBP1', 'PFDN5']",0.807918377009828,0,0,2
14,Selenium Micronutrient Network WP15,0.047085020617125335,2.617062343176993,7.997220056049011,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9114314705172119,0,0,7
15,Ferroptosis WP4313,0.08139278234969839,3.279324894514768,8.22608378558988,"['MAP1LC3A', 'GPX4', 'SAT2', 'FTL']",0.9834331145540643,0,0,4
16,mRNA Processing WP411,0.08139278234969839,3.279324894514768,8.22608378558988,"['LSM7', 'SNRPE', 'SRSF9', 'LSM2']",0.9834331145540643,0,0,4
17,Proteasome Degradation WP183,0.08139278234969839,3.279324894514768,8.22608378558988,"['PSMB6', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9834331145540643,0,0,4
18,Copper homeostasis WP3286,0.09501398687922889,4.094736842105263,9.63790972965761,"['SCO2', 'COX17', 'ATOX1']",0.9834331145540643,0,0,3
19,Eukaryotic Transcription Initiation WP405,0.09501398687922889,4.094736842105263,9.63790972965761,"['TAF13', 'POLR2I', 'POLR2K']",0.9834331145540643,0,0,3
20,p38 MAPK Signaling Pathway WP400,0.09501398687922889,4.094736842105263,9.63790972965761,"['TRADD', 'DDIT3', 'HRAS']",0.9834331145540643,0,0,3
21,Gastric acid production WP2596,0.10104777423718632,8.180672268907562,18.751424978073814,"['CCK', 'VIP']",0.9834331145540643,0,0,2
22,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.10104777423718632,8.180672268907562,18.751424978073814,"['MAP1LC3A', 'FTL']",0.9834331145540643,0,0,2
23,TNF-alpha signaling pathway WP231,0.11526703755151334,2.731364275668073,5.90112283334767,"['TRADD', 'BAX', 'FADD', 'HRAS']",0.9834331145540643,0,0,4
24,Cytosolic DNA-sensing pathway WP4655,0.11526703755151334,2.731364275668073,5.90112283334767,"['TRADD', 'FADD', 'POLR2K', 'POLR2L']",0.9834331145540643,0,0,4
25,DNA IR-double strand breaks and cellular response via ATM WP3959,0.14267772593749636,3.0694736842105264,5.976777425773937,"['DCLRE1C', 'KAT5', 'BAX']",0.9834331145540643,0,0,3
26,Apoptosis WP254,0.15416476059525389,2.3399638336347195,4.375108474824544,"['TRADD', 'CYCS', 'BAX', 'FADD']",0.9834331145540643,0,0,4
27,Apoptosis Modulation by HSP70 WP384,0.1761293226653497,4.088235294117647,7.099370895873521,"['CYCS', 'FADD']",0.9834331145540643,0,0,2
28,GABA receptor Signaling WP4159,0.1761293226653497,4.088235294117647,7.099370895873521,"['SLC32A1', 'AP2M1']",0.9834331145540643,0,0,2
29,Apoptosis Modulation and Signaling WP1772,0.192291807044022,1.8614261003267345,3.0690099626189675,"['ENDOG', 'TRADD', 'CYCS', 'BAX', 'FADD']",0.9834331145540643,0,0,5
30,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.19630388389533987,2.454315789473684,3.9958504110412254,"['PPP1R14B', 'MAP1LC3A', 'DDIT3']",0.9834331145540643,0,0,3
31,Leptin signaling pathway WP2034,0.19630388389533987,2.454315789473684,3.9958504110412254,"['RPS6', 'BAX', 'HRAS']",0.9834331145540643,0,0,3
32,15q11.2 copy number variation syndrome WP4940,0.19703190378284974,inf,inf,['TUBGCP4'],0.9834331145540643,0,0,1
33,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.19703190378284974,inf,inf,['IDH3B'],0.9834331145540643,0,0,1
34,Vitamin B12 Disorders WP4271,0.19703190378284974,inf,inf,['CUBN'],0.9834331145540643,0,0,1
35,EV release from cardiac cells and their functional effects WP3297,0.19703190378284974,inf,inf,['RGS16'],0.9834331145540643,0,0,1
36,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.19703190378284974,inf,inf,['RPS6'],0.9834331145540643,0,0,1
37,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.19703190378284974,inf,inf,['ELOB'],0.9834331145540643,0,0,1
38,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.19703190378284974,inf,inf,['MAP1LC3A'],0.9834331145540643,0,0,1
39,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.19703190378284974,inf,inf,['HRAS'],0.9834331145540643,0,0,1
40,Insulin signaling in adipocytes (diabetic condition) WP3635,0.19703190378284974,inf,inf,['RPS6'],0.9834331145540643,0,0,1
41,Insulin signaling in adipocytes (normal condition) WP3634,0.19703190378284974,inf,inf,['RPS6'],0.9834331145540643,0,0,1
42,LDLRAD4 and what we know about it WP4904,0.19703190378284974,inf,inf,['TGFBR2'],0.9834331145540643,0,0,1
43,Mitochondrial CII Assembly WP4920,0.19703190378284974,inf,inf,['SDHAF1'],0.9834331145540643,0,0,1
44,Nanoparticle triggered autophagic cell death WP2509,0.19703190378284974,inf,inf,['MAP1LC3A'],0.9834331145540643,0,0,1
45,Non-homologous end joining WP438,0.19703190378284974,inf,inf,['DCLRE1C'],0.9834331145540643,0,0,1
46,DNA Repair Pathways Full Network WP4946,0.19715158806900024,2.0464135021097047,3.32293015327747,"['POLD4', 'DCLRE1C', 'CENPX', 'APEX1']",0.9834331145540643,0,0,4
47,Ciliary landscape WP4352,0.21913608341153198,1.638135593220339,2.486791979246157,"['EXOSC4', 'NDUFA5', 'COPS7A', 'MYL6B', 'COX6C', 'LSM4']",0.9834331145540643,0,0,6
48,Head and Neck Squamous Cell Carcinoma WP4674,0.24321315146301184,1.8180965775902485,2.570455946512272,"['RPS6', 'FADD', 'HRAS', 'TGFBR2']",0.9834331145540643,0,0,4
49,16p11.2 proximal deletion syndrome WP4949,0.2537594370650597,2.0442105263157893,2.803366043589511,"['ASPHD1', 'SEZ6L2', 'CCT7']",0.9834331145540643,0,0,3
50,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.2565635295386449,2.724089635854342,3.7057942435459097,"['HRAS', 'TGFBR2']",0.9834331145540643,0,0,2
51,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.2565635295386449,2.724089635854342,3.7057942435459097,"['LDHA', 'RPS6']",0.9834331145540643,0,0,2
52,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.2565635295386449,2.724089635854342,3.7057942435459097,"['BAX', 'FADD']",0.9834331145540643,0,0,2
53,IL-2 signaling pathway WP49,0.2565635295386449,2.724089635854342,3.7057942435459097,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
54,Interleukin-11 Signaling Pathway WP2332,0.2565635295386449,2.724089635854342,3.7057942435459097,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
55,Rett syndrome causing genes WP4312,0.2565635295386449,2.724089635854342,3.7057942435459097,"['IMPDH2', 'TBL1X']",0.9834331145540643,0,0,2
56,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.313113315596382,1.7512781954887218,2.0335669437519805,"['APEX1', 'RPS6', 'HRAS']",0.9834331145540643,0,0,3
57,IL-18 signaling pathway WP4754,0.3340261826433155,1.23996373996374,1.359664753002042,"['CD81', 'TMSB4X', 'RGS16', 'COX17', 'CYCS', 'BAX', 'NDUFC1', 'FADD', 'LTB', 'RND2']",0.9834331145540643,0,0,10
58,ATM Signaling Network in Development and Disease  WP3878,0.3373382869054438,2.042016806722689,2.2189964295649465,"['DCLRE1C', 'KAT5']",0.9834331145540643,0,0,2
59,MET in type 1 papillary renal cell carcinoma WP4205,0.3373382869054438,2.042016806722689,2.2189964295649465,"['RPL11', 'HRAS']",0.9834331145540643,0,0,2
60,Serotonin and anxiety WP3947,0.3553074810281252,4.081761006289308,4.223690859766427,['CRH'],0.9834331145540643,0,0,1
61,Serotonin and anxiety-related events WP3944,0.3553074810281252,4.081761006289308,4.223690859766427,['CRH'],0.9834331145540643,0,0,1
62,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.3553074810281252,4.081761006289308,4.223690859766427,['HRAS'],0.9834331145540643,0,0,1
63,Amyotrophic lateral sclerosis (ALS) WP2447,0.3553074810281252,4.081761006289308,4.223690859766427,['BAX'],0.9834331145540643,0,0,1
64,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.3553074810281252,4.081761006289308,4.223690859766427,['HRAS'],0.9834331145540643,0,0,1
65,Biomarkers for pyrimidine metabolism disorders WP4584,0.3553074810281252,4.081761006289308,4.223690859766427,['NT5C'],0.9834331145540643,0,0,1
66,Canonical and non-canonical TGF-B signaling WP3874,0.3553074810281252,4.081761006289308,4.223690859766427,['TGFBR2'],0.9834331145540643,0,0,1
67,Transcriptional cascade regulating adipogenesis WP4211,0.3553074810281252,4.081761006289308,4.223690859766427,['DDIT3'],0.9834331145540643,0,0,1
68,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.3553074810281252,4.081761006289308,4.223690859766427,['CCK'],0.9834331145540643,0,0,1
69,Dual hijack model of Vif in HIV infection WP3300,0.3553074810281252,4.081761006289308,4.223690859766427,['ELOB'],0.9834331145540643,0,0,1
70,Ebstein-Barr virus LMP1 signaling WP262,0.3553074810281252,4.081761006289308,4.223690859766427,['TRADD'],0.9834331145540643,0,0,1
71,Energy Metabolism WP1541,0.3553074810281252,4.081761006289308,4.223690859766427,['UCP3'],0.9834331145540643,0,0,1
72,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3553074810281252,4.081761006289308,4.223690859766427,['MAFF'],0.9834331145540643,0,0,1
73,Fatty acid transporters WP5061,0.3553074810281252,4.081761006289308,4.223690859766427,['FABP6'],0.9834331145540643,0,0,1
74,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3553074810281252,4.081761006289308,4.223690859766427,['H2AFZ'],0.9834331145540643,0,0,1
75,Homologous recombination WP186,0.3553074810281252,4.081761006289308,4.223690859766427,['POLD4'],0.9834331145540643,0,0,1
76,MAPK Cascade WP422,0.3553074810281252,4.081761006289308,4.223690859766427,['HRAS'],0.9834331145540643,0,0,1
77,MTHFR deficiency WP4288,0.3553074810281252,4.081761006289308,4.223690859766427,['CYCS'],0.9834331145540643,0,0,1
78,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3553074810281252,4.081761006289308,4.223690859766427,['SCO2'],0.9834331145540643,0,0,1
79,Peroxiredoxin 2 induced ovarian failure WP4873,0.3553074810281252,4.081761006289308,4.223690859766427,['BAX'],0.9834331145540643,0,0,1
80,Phosphoinositides metabolism WP4971,0.3553074810281252,4.081761006289308,4.223690859766427,['PIP4P1'],0.9834331145540643,0,0,1
81,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.3553074810281252,4.081761006289308,4.223690859766427,['HRAS'],0.9834331145540643,0,0,1
82,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.3553074810281252,4.081761006289308,4.223690859766427,['LDHA'],0.9834331145540643,0,0,1
83,Pyrimidine metabolism and related diseases WP4225,0.3553074810281252,4.081761006289308,4.223690859766427,['NT5C'],0.9834331145540643,0,0,1
84,Hepatitis B infection WP4666,0.35719365421521615,1.3622269203664552,1.4023815496032936,"['CYCS', 'BAX', 'FADD', 'HRAS', 'TGFBR2']",0.9834331145540643,0,0,5
85,Integrated breast cancer pathway WP1984,0.35719365421521615,1.3622269203664552,1.4023815496032936,"['TRADD', 'BAX', 'FADD', 'FAU', 'TGFBR2']",0.9834331145540643,0,0,5
86,Alzheimer's disease WP2059,0.3727190089488617,1.5315789473684212,1.5115619310525796,"['ATP5MD', 'CYCS', 'FADD']",0.9834331145540643,0,0,3
87,Canonical and non-canonical Notch signaling WP3845,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['MAML2', 'DLK2']",0.9834331145540643,0,0,2
88,Computational Model of Aerobic Glycolysis WP4629,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['LDHA', 'PFKM']",0.9834331145540643,0,0,2
89,Fas ligand pathway and stress induction of heat shock proteins WP314,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['CYCS', 'FADD']",0.9834331145540643,0,0,2
90,Kit receptor signaling pathway WP304,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
91,MECP2 and Associated Rett Syndrome WP3584,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['SST', 'RPS6']",0.9834331145540643,0,0,2
92,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['TRADD', 'FADD']",0.9834331145540643,0,0,2
93,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4152024843262423,1.6327731092436975,1.4351895432573074,"['TRADD', 'FADD']",0.9834331145540643,0,0,2
94,Acute viral myocarditis WP4298,0.4312414613862305,1.360701754385965,1.144468706871478,"['ENDOG', 'CYCS', 'BAX']",0.9834331145540643,0,0,3
95,Endometrial cancer WP4155,0.4312414613862305,1.360701754385965,1.144468706871478,"['BAX', 'FGF1', 'HRAS']",0.9834331145540643,0,0,3
96,Non-small cell lung cancer WP4255,0.4312414613862305,1.360701754385965,1.144468706871478,"['CYCS', 'BAX', 'HRAS']",0.9834331145540643,0,0,3
97,16p11.2 distal deletion syndrome WP4950,0.482437252869945,2.039832285115304,1.4868427534318909,['CD81'],0.9834331145540643,0,0,1
98,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.482437252869945,2.039832285115304,1.4868427534318909,['VIP'],0.9834331145540643,0,0,1
99,Vitamin D-sensitive calcium signaling in depression WP4698,0.482437252869945,2.039832285115304,1.4868427534318909,['GPX4'],0.9834331145540643,0,0,1
100,EDA signaling in hair follicle development WP3930,0.482437252869945,2.039832285115304,1.4868427534318909,['LTB'],0.9834331145540643,0,0,1
101,Glutathione metabolism WP100,0.482437252869945,2.039832285115304,1.4868427534318909,['GPX4'],0.9834331145540643,0,0,1
102,Glycosaminoglycan degradation WP4815,0.482437252869945,2.039832285115304,1.4868427534318909,['SGSH'],0.9834331145540643,0,0,1
103,Glycosylation and related congenital defects WP4521,0.482437252869945,2.039832285115304,1.4868427534318909,['DPM3'],0.9834331145540643,0,0,1
104,Histone Modifications WP2369,0.482437252869945,2.039832285115304,1.4868427534318909,['SET'],0.9834331145540643,0,0,1
105,IL17 signaling pathway WP2112,0.482437252869945,2.039832285115304,1.4868427534318909,['IL17RE'],0.9834331145540643,0,0,1
106,Interferon type I signaling pathways WP585,0.482437252869945,2.039832285115304,1.4868427534318909,['RPS6'],0.9834331145540643,0,0,1
107,Joubert Syndrome WP4656,0.482437252869945,2.039832285115304,1.4868427534318909,['KAT5'],0.9834331145540643,0,0,1
108,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.482437252869945,2.039832285115304,1.4868427534318909,['BAX'],0.9834331145540643,0,0,1
109,miRNA regulation of p53 pathway in prostate cancer WP3982,0.482437252869945,2.039832285115304,1.4868427534318909,['BAX'],0.9834331145540643,0,0,1
110,Nanoparticle-mediated activation of receptor signaling WP2643,0.482437252869945,2.039832285115304,1.4868427534318909,['HRAS'],0.9834331145540643,0,0,1
111,NO/cGMP/PKG mediated Neuroprotection WP4008,0.482437252869945,2.039832285115304,1.4868427534318909,['CYCS'],0.9834331145540643,0,0,1
112,Overview of nanoparticle effects WP3287,0.482437252869945,2.039832285115304,1.4868427534318909,['BAX'],0.9834331145540643,0,0,1
113,RalA downstream regulated genes WP2290,0.482437252869945,2.039832285115304,1.4868427534318909,['HRAS'],0.9834331145540643,0,0,1
114,"Relationship between inflammation, COX-2 and EGFR WP4483",0.482437252869945,2.039832285115304,1.4868427534318909,['HRAS'],0.9834331145540643,0,0,1
115,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.4876499279799278,1.224,0.8790247692926474,"['CYCS', 'BAX', 'TGFBR2']",0.9834331145540643,0,0,3
116,Complement system WP2806,0.4876499279799278,1.224,0.8790247692926474,"['FKBP2', 'RPS19', 'C5AR1']",0.9834331145540643,0,0,3
117,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.4876499279799278,1.224,0.8790247692926474,"['RPS6', 'BAX', 'HRAS']",0.9834331145540643,0,0,3
118,Genotoxicity pathway WP4286,0.4876499279799278,1.224,0.8790247692926474,"['RPS27', 'BLOC1S2', 'TRIAP1']",0.9834331145540643,0,0,3
119,Synaptic Vesicle Pathway WP2267,0.4881686486045253,1.3599439775910365,0.9752081309912892,"['SLC32A1', 'AP2M1']",0.9834331145540643,0,0,2
120,Base Excision Repair WP4752,0.4881686486045253,1.3599439775910365,0.9752081309912892,"['POLD4', 'APEX1']",0.9834331145540643,0,0,2
121,Modulators of TCR signaling and T cell activation WP5072,0.4881686486045253,1.3599439775910365,0.9752081309912892,"['NDUFB10', 'ELOB']",0.9834331145540643,0,0,2
122,Oxidative Damage WP3941,0.4881686486045253,1.3599439775910365,0.9752081309912892,"['C5AR1', 'CYCS']",0.9834331145540643,0,0,2
123,Prolactin Signaling Pathway WP2037,0.4881686486045253,1.3599439775910365,0.9752081309912892,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
124,22q11.2 copy number variation syndrome WP4657,0.54119153291172,1.1121531100478468,0.6828420217693723,"['RANBP1', 'MRPL40', 'THAP7']",0.9834331145540643,0,0,3
125,Androgen receptor signaling pathway WP138,0.54119153291172,1.1121531100478468,0.6828420217693723,"['KAT5', 'BAG1', 'STUB1']",0.9834331145540643,0,0,3
126,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.5551426668613284,1.1650660264105641,0.6856764726363552,"['HRAS', 'TGFBR2']",0.9834331145540643,0,0,2
127,TGF-beta Receptor Signaling WP560,0.5551426668613284,1.1650660264105641,0.6856764726363552,"['HRAS', 'TGFBR2']",0.9834331145540643,0,0,2
128,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5551426668613284,1.1650660264105641,0.6856764726363552,"['IFI27L2', 'HRAS']",0.9834331145540643,0,0,2
129,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.5551426668613284,1.1650660264105641,0.6856764726363552,"['LDHA', 'BAX']",0.9834331145540643,0,0,2
130,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.5551426668613284,1.1650660264105641,0.6856764726363552,"['BAX', 'HRAS']",0.9834331145540643,0,0,2
131,BDNF-TrkB Signaling WP3676,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HRAS'],0.9834331145540643,0,0,1
132,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5845398167737796,1.3591893780573026,0.7297900683087747,['SST'],0.9834331145540643,0,0,1
133,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.5845398167737796,1.3591893780573026,0.7297900683087747,['RPS6'],0.9834331145540643,0,0,1
134,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.5845398167737796,1.3591893780573026,0.7297900683087747,['FADD'],0.9834331145540643,0,0,1
135,TP53 network WP1742,0.5845398167737796,1.3591893780573026,0.7297900683087747,['BAX'],0.9834331145540643,0,0,1
136,Type II interferon signaling (IFNG) WP619,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HLA-B'],0.9834331145540643,0,0,1
137,White fat cell differentiation WP4149,0.5845398167737796,1.3591893780573026,0.7297900683087747,['DDIT3'],0.9834331145540643,0,0,1
138,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HRAS'],0.9834331145540643,0,0,1
139,ERK Pathway in Huntington's Disease WP3853,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HRAS'],0.9834331145540643,0,0,1
140,Genes targeted by miRNAs in adipocytes WP1992,0.5845398167737796,1.3591893780573026,0.7297900683087747,['TMSB4X'],0.9834331145540643,0,0,1
141,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.5845398167737796,1.3591893780573026,0.7297900683087747,['FGF1'],0.9834331145540643,0,0,1
142,HIF1A and PPARG regulation of glycolysis WP2456,0.5845398167737796,1.3591893780573026,0.7297900683087747,['LDHA'],0.9834331145540643,0,0,1
143,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.5845398167737796,1.3591893780573026,0.7297900683087747,['TGFBR2'],0.9834331145540643,0,0,1
144,IL-5 signaling pathway WP127,0.5845398167737796,1.3591893780573026,0.7297900683087747,['RPS6'],0.9834331145540643,0,0,1
145,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.5845398167737796,1.3591893780573026,0.7297900683087747,['TGFBR2'],0.9834331145540643,0,0,1
146,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HRAS'],0.9834331145540643,0,0,1
147,Major receptors targeted by epinephrine and norepinephrine WP4589,0.5845398167737796,1.3591893780573026,0.7297900683087747,['ADRA2A'],0.9834331145540643,0,0,1
148,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.5845398167737796,1.3591893780573026,0.7297900683087747,['VEGFB'],0.9834331145540643,0,0,1
149,Nucleotide metabolism WP404,0.5845398167737796,1.3591893780573026,0.7297900683087747,['NME2'],0.9834331145540643,0,0,1
150,PDGF Pathway WP2526,0.5845398167737796,1.3591893780573026,0.7297900683087747,['HRAS'],0.9834331145540643,0,0,1
151,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.5845398167737796,1.3591893780573026,0.7297900683087747,['BAX'],0.9834331145540643,0,0,1
152,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5845398167737796,1.3591893780573026,0.7297900683087747,['BAX'],0.9834331145540643,0,0,1
153,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.5845398167737796,1.3591893780573026,0.7297900683087747,['ANAPC11'],0.9834331145540643,0,0,1
154,SARS-CoV-2 mitochondrial interactions WP5038,0.5845398167737796,1.3591893780573026,0.7297900683087747,['NDUFB9'],0.9834331145540643,0,0,1
155,EGF/EGFR signaling pathway WP437,0.591355335804144,1.0189473684210526,0.5352919736046154,"['NDUFA13', 'HRAS', 'AP2M1']",0.9834331145540643,0,0,3
156,Endoderm differentiation WP2853,0.591355335804144,1.0189473684210526,0.5352919736046154,"['DUSP4', 'TCEAL2', 'NME1']",0.9834331145540643,0,0,3
157,7q11.23 copy number variation syndrome WP4932,0.6156499579098604,1.01890756302521,0.49424834590015215,"['ATP5F1E', 'ATP5MC1']",0.9834331145540643,0,0,2
158,Thermogenesis WP4321,0.6156499579098604,1.01890756302521,0.49424834590015215,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
159,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6158420323682798,0.9494252873563218,0.4602479493773988,"['SET', 'RPS6', 'RPL10A', 'RPL7', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'FADD', 'CCT7', 'HRAS']",0.9834331145540643,0,0,14
160,Type 2 papillary renal cell carcinoma WP4241,0.6665338090761715,1.0188679245283019,0.413318459907928,['ELOB'],0.9834331145540643,0,0,1
161,DNA Replication WP466,0.6665338090761715,1.0188679245283019,0.413318459907928,['POLD4'],0.9834331145540643,0,0,1
162,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.6665338090761715,1.0188679245283019,0.413318459907928,['CD81'],0.9834331145540643,0,0,1
163,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.6665338090761715,1.0188679245283019,0.413318459907928,['MAP1LC3A'],0.9834331145540643,0,0,1
164,Glycolysis in senescence WP5049,0.6665338090761715,1.0188679245283019,0.413318459907928,['LDHA'],0.9834331145540643,0,0,1
165,"GPCRs, Class B Secretin-like WP334",0.6665338090761715,1.0188679245283019,0.413318459907928,['ADGRL4'],0.9834331145540643,0,0,1
166,Integrin-mediated Cell Adhesion WP185,0.6665338090761715,1.0188679245283019,0.413318459907928,['HRAS'],0.9834331145540643,0,0,1
167,Kallmann's Syndrome WP5074,0.6665338090761715,1.0188679245283019,0.413318459907928,['CHD7'],0.9834331145540643,0,0,1
168,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6665338090761715,1.0188679245283019,0.413318459907928,['OMG'],0.9834331145540643,0,0,1
169,PDGFR-beta pathway WP3972,0.6665338090761715,1.0188679245283019,0.413318459907928,['HRAS'],0.9834331145540643,0,0,1
170,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6696345630357606,0.9052287581699346,0.3630176823708435,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
171,Melanoma WP4685,0.6696345630357606,0.9052287581699346,0.3630176823708435,"['BAX', 'HRAS']",0.9834331145540643,0,0,2
172,Gastrin signaling pathway WP4659,0.6804815833938037,0.8724812030075187,0.3358655832377741,"['KAT5', 'RPS6', 'HRAS']",0.9834331145540643,0,0,3
173,DNA damage response WP707,0.7173131305461637,0.8142857142857143,0.2705405742658636,"['CYCS', 'BAX']",0.9834331145540643,0,0,2
174,Exercise-induced Circadian Regulation WP410,0.7173131305461637,0.8142857142857143,0.2705405742658636,"['GSTP1', 'UCP3']",0.9834331145540643,0,0,2
175,Glycolysis and Gluconeogenesis WP534,0.7173131305461637,0.8142857142857143,0.2705405742658636,"['LDHA', 'PFKM']",0.9834331145540643,0,0,2
176,miRNA regulation of DNA damage response WP1530,0.7173131305461637,0.8142857142857143,0.2705405742658636,"['CYCS', 'BAX']",0.9834331145540643,0,0,2
177,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7323728335354417,0.8146750524109014,0.2537432208120153,['HRAS'],0.9834331145540643,0,0,1
178,AGE/RAGE pathway WP2324,0.7323728335354417,0.8146750524109014,0.2537432208120153,['CYCS'],0.9834331145540643,0,0,1
179,Alpha 6 Beta 4 signaling pathway WP244,0.7323728335354417,0.8146750524109014,0.2537432208120153,['HRAS'],0.9834331145540643,0,0,1
180,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.7323728335354417,0.8146750524109014,0.2537432208120153,['HRAS'],0.9834331145540643,0,0,1
181,Translation Factors WP107,0.7323728335354417,0.8146750524109014,0.2537432208120153,['EEF1B2'],0.9834331145540643,0,0,1
182,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7323728335354417,0.8146750524109014,0.2537432208120153,['RPS6'],0.9834331145540643,0,0,1
183,Unfolded protein response WP4925,0.7323728335354417,0.8146750524109014,0.2537432208120153,['DDIT3'],0.9834331145540643,0,0,1
184,Vitamin A and carotenoid metabolism WP716,0.7323728335354417,0.8146750524109014,0.2537432208120153,['RBP4'],0.9834331145540643,0,0,1
185,Cori Cycle WP1946,0.7323728335354417,0.8146750524109014,0.2537432208120153,['LDHA'],0.9834331145540643,0,0,1
186,DNA Mismatch Repair WP531,0.7323728335354417,0.8146750524109014,0.2537432208120153,['POLD4'],0.9834331145540643,0,0,1
187,IL-3 signaling pathway WP286,0.7323728335354417,0.8146750524109014,0.2537432208120153,['HRAS'],0.9834331145540643,0,0,1
188,IL-6 signaling pathway WP364,0.7323728335354417,0.8146750524109014,0.2537432208120153,['VIP'],0.9834331145540643,0,0,1
189,Integrated Cancer Pathway WP1971,0.7323728335354417,0.8146750524109014,0.2537432208120153,['BAX'],0.9834331145540643,0,0,1
190,Nephrotic syndrome WP4758,0.7323728335354417,0.8146750524109014,0.2537432208120153,['CUBN'],0.9834331145540643,0,0,1
191,Nucleotide Excision Repair WP4753,0.7323728335354417,0.8146750524109014,0.2537432208120153,['POLD4'],0.9834331145540643,0,0,1
192,One-carbon metabolism and related pathways WP3940,0.7323728335354417,0.8146750524109014,0.2537432208120153,['GPX4'],0.9834331145540643,0,0,1
193,Pathways affected in adenoid cystic carcinoma WP3651,0.7323728335354417,0.8146750524109014,0.2537432208120153,['HRAS'],0.9834331145540643,0,0,1
194,Photodynamic therapy-induced unfolded protein response WP3613,0.7323728335354417,0.8146750524109014,0.2537432208120153,['DDIT3'],0.9834331145540643,0,0,1
195,PPAR signaling pathway WP3942,0.7323728335354417,0.8146750524109014,0.2537432208120153,['FABP6'],0.9834331145540643,0,0,1
196,Myometrial relaxation and contraction pathways WP289,0.756120837040492,0.774362065501306,0.2164760734298186,"['RGS16', 'MAFF', 'CRH', 'IGFBP6']",0.9834331145540643,0,0,4
197,B Cell Receptor Signaling Pathway WP23,0.7590700218010727,0.739877769289534,0.20395563110274947,"['CD81', 'HRAS']",0.9834331145540643,0,0,2
198,DNA damage response (only ATM dependent) WP710,0.7590700218010727,0.739877769289534,0.20395563110274947,"['BAX', 'HRAS']",0.9834331145540643,0,0,2
199,Pancreatic adenocarcinoma pathway WP4263,0.7590700218010727,0.739877769289534,0.20395563110274947,"['BAX', 'TGFBR2']",0.9834331145540643,0,0,2
200,NRF2 pathway WP2884,0.7839477249214389,0.7387802071346375,0.17982866094024283,"['GSTP1', 'MAFF', 'FTL', 'TGFBR2']",0.9834331145540643,0,0,4
201,Toll-like Receptor Signaling Pathway WP75,0.7852344778974896,0.6785464709993012,0.16405415339976567,['FADD'],0.9834331145540643,0,0,1
202,Vitamin B12 metabolism WP1533,0.7852344778974896,0.6785464709993012,0.16405415339976567,['CUBN'],0.9834331145540643,0,0,1
203,Fragile X Syndrome  WP4549,0.7852344778974896,0.6785464709993012,0.16405415339976567,['AP2M1'],0.9834331145540643,0,0,1
204,G Protein Signaling Pathways WP35,0.7852344778974896,0.6785464709993012,0.16405415339976567,['HRAS'],0.9834331145540643,0,0,1
205,Heart Development WP1591,0.7852344778974896,0.6785464709993012,0.16405415339976567,['VEGFB'],0.9834331145540643,0,0,1
206,Monoamine GPCRs WP58,0.7852344778974896,0.6785464709993012,0.16405415339976567,['ADRA2A'],0.9834331145540643,0,0,1
207,p53 transcriptional gene network WP4963,0.7852344778974896,0.6785464709993012,0.16405415339976567,['BAX'],0.9834331145540643,0,0,1
208,Parkinson's disease pathway WP2371,0.7852344778974896,0.6785464709993012,0.16405415339976567,['CYCS'],0.9834331145540643,0,0,1
209,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7852344778974896,0.6785464709993012,0.16405415339976567,['GSTP1'],0.9834331145540643,0,0,1
210,Pre-implantation embryo WP3527,0.7852344778974896,0.6785464709993012,0.16405415339976567,['DDIT3'],0.9834331145540643,0,0,1
211,MAPK Signaling Pathway WP382,0.7855899803963873,0.7520945893038916,0.1814956739449836,"['DUSP4', 'DDIT3', 'FGF1', 'HRAS', 'TGFBR2']",0.9834331145540643,0,0,5
212,Regulation of Actin Cytoskeleton WP51,0.7953830472235554,0.6778711484593838,0.15518603168088943,"['TMSB4X', 'FGF1']",0.9834331145540643,0,0,2
213,ESC Pluripotency Pathways WP3931,0.8267718690186462,0.6254040077569489,0.11896840027084422,"['FGF1', 'HRAS']",0.9834331145540643,0,0,2
214,Oncostatin M Signaling Pathway WP2374,0.8267718690186462,0.6254040077569489,0.11896840027084422,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
215,Pathways in clear cell renal cell carcinoma WP4018,0.8267718690186462,0.6254040077569489,0.11896840027084422,"['LDHA', 'PFKM']",0.9834331145540643,0,0,2
216,Aryl Hydrocarbon Receptor Netpath WP2586,0.8276723728318645,0.5813117699910153,0.1099480803796686,['HRAS'],0.9834331145540643,0,0,1
217,Differentiation Pathway WP2848,0.8276723728318645,0.5813117699910153,0.1099480803796686,['FGF1'],0.9834331145540643,0,0,1
218,Folate Metabolism WP176,0.8276723728318645,0.5813117699910153,0.1099480803796686,['GPX4'],0.9834331145540643,0,0,1
219,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.8276723728318645,0.5813117699910153,0.1099480803796686,['DDIT3'],0.9834331145540643,0,0,1
220,Lung fibrosis WP3624,0.8276723728318645,0.5813117699910153,0.1099480803796686,['FGF1'],0.9834331145540643,0,0,1
221,Notch Signaling Pathway Netpath WP61,0.8276723728318645,0.5813117699910153,0.1099480803796686,['MAML2'],0.9834331145540643,0,0,1
222,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.8276723728318645,0.5813117699910153,0.1099480803796686,['NDUFA13'],0.9834331145540643,0,0,1
223,Phosphodiesterases in neuronal function WP4222,0.8276723728318645,0.5813117699910153,0.1099480803796686,['PDE10A'],0.9834331145540643,0,0,1
224,Small cell lung cancer WP4658,0.8537630457349306,0.5804321728691476,0.09176724808535458,"['CYCS', 'BAX']",0.9834331145540643,0,0,2
225,Ebola Virus Pathway on Host WP4217,0.8537630457349306,0.5804321728691476,0.09176724808535458,"['HLA-B', 'VPS11']",0.9834331145540643,0,0,2
226,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8537630457349306,0.5804321728691476,0.09176724808535458,"['HRAS', 'TGFBR2']",0.9834331145540643,0,0,2
227,Breast cancer pathway WP4262,0.8606134488748567,0.6088421052631579,0.0913931857556308,"['BAX', 'FGF1', 'HRAS']",0.9834331145540643,0,0,3
228,Sleep regulation WP3591,0.8617385056660692,0.5083857442348009,0.07564953337294167,['CRH'],0.9834331145540643,0,0,1
229,Amino Acid metabolism WP3925,0.8617385056660692,0.5083857442348009,0.07564953337294167,['LDHA'],0.9834331145540643,0,0,1
230,Aryl Hydrocarbon Receptor Pathway WP2873,0.8617385056660692,0.5083857442348009,0.07564953337294167,['BAX'],0.9834331145540643,0,0,1
231,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8617385056660692,0.5083857442348009,0.07564953337294167,['TMSB4X'],0.9834331145540643,0,0,1
232,Bladder cancer WP2828,0.8617385056660692,0.5083857442348009,0.07564953337294167,['HRAS'],0.9834331145540643,0,0,1
233,Chemokine signaling pathway WP3929,0.8617385056660692,0.5083857442348009,0.07564953337294167,['HRAS'],0.9834331145540643,0,0,1
234,Retinoblastoma gene in cancer WP2446,0.8617385056660692,0.5083857442348009,0.07564953337294167,['H2AFZ'],0.9834331145540643,0,0,1
235,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8768671834064755,0.5414565826330532,0.07114725543173629,"['RPS6', 'HRAS']",0.9834331145540643,0,0,2
236,Ciliopathies WP4803,0.8768671834064755,0.5414565826330532,0.07114725543173629,"['CCDC65', 'CCDC28B']",0.9834331145540643,0,0,2
237,Ras signaling WP4223,0.8768671834064755,0.5414565826330532,0.07114725543173629,"['RASAL1', 'HRAS']",0.9834331145540643,0,0,2
238,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.881463854134936,0.6329281183932347,0.07985735270444767,"['COL11A1', 'RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9834331145540643,0,0,5
239,Complement and Coagulation Cascades WP558,0.8890815980285822,0.4516655019799674,0.05310062445825377,['C5AR1'],0.9834331145540643,0,0,1
240,Ectoderm Differentiation WP2858,0.8890815980285822,0.4516655019799674,0.05310062445825377,['TBL1X'],0.9834331145540643,0,0,1
241,ErbB signaling pathway WP673,0.8890815980285822,0.4516655019799674,0.05310062445825377,['HRAS'],0.9834331145540643,0,0,1
242,Mesodermal commitment pathway WP2857,0.8890815980285822,0.4516655019799674,0.05310062445825377,['RPL38'],0.9834331145540643,0,0,1
243,Metabolic reprogramming in colon cancer WP4290,0.8890815980285822,0.4516655019799674,0.05310062445825377,['LDHA'],0.9834331145540643,0,0,1
244,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8890815980285822,0.4516655019799674,0.05310062445825377,['BAX'],0.9834331145540643,0,0,1
245,Regulation of toll-like receptor signaling pathway WP1449,0.8890815980285822,0.4516655019799674,0.05310062445825377,['FADD'],0.9834331145540643,0,0,1
246,Spinal Cord Injury WP2431,0.8967785297754282,0.5529186602870814,0.06023846902214783,"['APEX1', 'OMG', 'LTB']",0.9879145592241505,0,0,3
247,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9110262232273739,0.40628930817610065,0.03785949917273646,['RBP4'],0.9907892595097528,0,0,1
248,Male infertility WP4673,0.9110262232273739,0.40628930817610065,0.03785949917273646,['PEX10'],0.9907892595097528,0,0,1
249,Senescence and Autophagy in Cancer WP615,0.9132983188062439,0.4772614928324271,0.04328413629106898,"['MAP1LC3A', 'HRAS']",0.9907892595097528,0,0,2
250,Insulin Signaling WP481,0.927468468338079,0.4505135387488329,0.0339220843266342,"['HRAS', 'PFKM']",0.9907892595097528,0,0,2
251,T-cell receptor (TCR) signaling pathway WP69,0.9286364277323882,0.36916333142748237,0.02733210569035707,['HRAS'],0.9907892595097528,0,0,1
252,Glioblastoma signaling pathways WP2261,0.9286364277323882,0.36916333142748237,0.02733210569035707,['HRAS'],0.9907892595097528,0,0,1
253,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9286364277323882,0.36916333142748237,0.02733210569035707,['STUB1'],0.9907892595097528,0,0,1
254,Peptide GPCRs WP24,0.9286364277323882,0.36916333142748237,0.02733210569035707,['C5AR1'],0.9907892595097528,0,0,1
255,Hippo-Merlin Signaling Dysregulation WP4541,0.9427668870163272,0.3382250174703005,0.01993370758938788,['HRAS'],0.9974141393550485,0,0,1
256,Circadian rhythm related genes WP3594,0.9495101500086789,0.4050420168067227,0.020984845722335513,"['CRH', 'RPS27A']",0.9974141393550485,0,0,2
257,Corticotropin-releasing hormone signaling pathway WP2355,0.9541040331816135,0.31204644412191584,0.014660742039011401,['CRH'],0.9974141393550485,0,0,1
258,Proximal tubule transport WP4917,0.9631991179858396,0.28960766696615753,0.010858874266469958,['SLC7A9'],0.9974141393550485,0,0,1
259,PI3K-Akt signaling pathway WP4172,0.9695881919800846,0.4481950304735115,0.013841984497187716,"['RPS6', 'VEGFB', 'FGF1', 'HRAS']",0.9974141393550485,0,0,4
260,Focal Adhesion WP306,0.9759727439407618,0.33683473389355745,0.008192029312928693,"['VEGFB', 'HRAS']",0.9974141393550485,0,0,2
261,Metapathway biotransformation Phase I and II WP702,0.9759727439407618,0.33683473389355745,0.008192029312928693,"['GPX4', 'GSTP1']",0.9974141393550485,0,0,2
262,Allograft Rejection WP2328,0.9810394264313113,0.23813047231471204,0.004558443566647603,['HLA-B'],0.9974141393550485,0,0,1
263,Cell cycle WP179,0.9810394264313113,0.23813047231471204,0.004558443566647603,['ANAPC11'],0.9974141393550485,0,0,1
264,TGF-beta Signaling Pathway WP366,0.9848027618605354,0.22478453296063358,0.003442327775474985,['TGFBR2'],0.9974141393550485,0,0,1
265,Nuclear Receptors Meta-Pathway WP2882,0.9852784036727145,0.4275561153344429,0.0063410994645434066,"['GSTP1', 'MAFF', 'BAX', 'FTL', 'TGFBR2']",0.9974141393550485,0,0,5
266,Osteoblast differentiation WP4787,0.9878202993303912,0.21284342932803707,0.002608285770438775,['FGF1'],0.9974141393550485,0,0,1
267,Adipogenesis WP236,0.9902395870509216,0.2020964360587002,0.001982234197481204,['DDIT3'],0.9974141393550485,0,0,1
268,"GPCRs, Class A Rhodopsin-like WP455",0.9907543107890988,0.27803535207186325,0.002582585830639655,"['GPR22', 'ADRA2A']",0.9974141393550485,0,0,2
269,Calcium Regulation in the Cardiac Cell WP536,0.9921790317500143,0.19237296595787162,0.0015104572073471705,['RGS16'],0.9974141393550485,0,0,1
270,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9937336443758785,0.1835334476843911,0.0011537044002453175,['SST'],0.9974141393550485,0,0,1
271,Vitamin D Receptor Pathway WP2877,0.9974195261743841,0.1549750040316078,0.0004004258081717689,['ZNF257'],0.9974195261743841,0,0,1
